NVST Stock Analysis: Buy, Sell, or Hold?
NVST - Envista Holdings Corporation Common stock, $0.01 par value per share
$25.26
-0.25 (-0.98%)
▼
5d:
+2.35%
30d:
+6.9%
90d:
-2.17%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Smart Money Distribution
None View Scanner →
Strength: 5.1/10
Get Alerted When NVST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NVST shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NVST shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.28
Based on 6.9% avg growth
INTRINSIC VALUE TODAY
$23.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NVST is currently trading at $25.26, which is considered extended relative to its 30-day fair value range of $23.01 to $24.77. The stock's valuation (Forward PE: 16.1) is in line with its historical norms (17.0). Remarkably, the market is currently pricing in an annual earnings decline of 1.9% over the next few years. This pessimistic expectation contrasts with the company's recent 130.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NVST is in a strong uptrend. Immediate support is located at $23.69, while resistance sits at $26.20.
Market Sentiment: NVST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.69 (+17.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NVST is in a strong uptrend. Immediate support is located at $23.69, while resistance sits at $26.20.
Market Sentiment: NVST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.69 (+17.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.01 -
$24.77
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
59.5%
Protect Your Profits
Holding NVST? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($29.69)
Trading Range Analysis
30-Day Trading Range
$23.01 -
$24.77
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$23.69
Resistance Level
$26.20
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.07
Wall Street Target
$29.69
(+17.5%)
Revenue Growth (YoY)
14.4%
Earnings Growth (YoY)
130.0%
Profit Margin
2.4%
Valuation Discount vs History
-1.9% cheaper
PE vs Historical
16.1 vs 17.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.9%
(market-implied from PE analysis)
1-Year Target
$24.78
(-2%)
2-Year Target
$24.31
(-4%)
3-Year Target
$23.85
(-6%)
3-Yr Target (if PE normalizes)
(PE: 16→17)
$25.23
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.8%)
$45.28
(+79%)
Base:
(SPY PE: 16.1, Growth: 9.8%)
$33.40
(+32%)
Bear:
(PE: 13.7, Growth: 9.8%)
$28.39
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Forward PE: 20.33 | Forward EPS (Implied): $1.24
Bull Case
$30.50
(+21%)
Analyst growth 15.0%, PE expands to 21.3
Base Case
$25.26
(0%)
Market implied 0.0%, PE stable at 20.3
Bear Case
$19.32
(-24%)
Severe decline -15.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.1 to 17.0
Stabilization Target:
$26.73
(+5.8%)
PE Expansion Potential:
+5.8%
Share & Embed Analysis
Last updated: June 23, 2026 9:38 PM ET
Data refreshes hourly during market hours. Next update: 10:38 PM
Data refreshes hourly during market hours. Next update: 10:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mischa Reis
SELL
9675 shares
2026-02-10
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 54 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 50 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 65 BUY |
Advanced NVST Option Strategies
Professional options setups generated by AI based on today's NVST price and gamma walls.
